Novasep Expands Cryogenics Production Capacity
By

By
Novasep, a Lyon, France-headquartered contract manufacturing organization and life-science service provider, is investing EUR 4 million ($4.6 million) to expand cGMP capacity at its facility in Chasse-sur-Rhône, France for clinical…

Incyte, Macrogenics in $900-Million Immuno-Oncology Deal
By

By
Incyte Corporation, a Wilmington, Delaware-based biopharmaceutical company, and MacroGenics, a Rockville, Maryland-based clinical-stage biopharmaceutical company, have signed a license agreement worth up to $900 million for MacroGenics’ MGA012, an investigational…

Sanofi Files Patent Suit Against Mylan Over Sanofi’s Top-Selling Drug Lantus
By

By
Sanofi has filed a patent-infringement suit in a federal district court against Mylan for Sanofi’s top-selling drug, Lantus (insulin glargine). Lantus had 2016 sales of EUR 5.7 billion ($6.7 billion).…

Catalent Completes $950-Million Acquisition of Cook Pharmica
By

By
Catalent has completed its previously announced $950-million acquisition of Cook Pharmica, a Bloomington, Indiana-based contract development and manufacturing organization of biologic-based drug substances and parenteral drug products. Catalent agreed to…

Merck & Co., J&J, Novartis, Teva and Novo Nordisk Lead Pipeline News
By

By
A roundup of the latest market developments from the pipelines of the pharmaceutical majors and other related news, featuring news from Merck & Co., Johnson & Johnson, Novartis, Celgene, Teva…

AstraZeneca, GSK, Bayer Lead Drug Approval News
By

By
A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from AstraZeneca, GlaxoSmithKline, and Bayer. Editor’s Note: This article was updated on a continuous basis for…

Ampac Fine Chemicals Makes Senior Appointments
By

By
Ampac Fine Chemicals (AFC) has appointed Don Whiteaker to the position of vice president, supply chain, and Jeff Butler to the position of executive director, project management. Both are current…

Almac Group Announces Successful MHRA Inspection at Charnwood Facilities
By

By
Almac Group, a Craigavon, Ireland-based contract development and manufacturing organization, has successfully completed an inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) of its new pharmaceutical development…

Alcami Launches Sales Office in Japan
By

By
Alcami Corporation, a contract development and manufacturing organization for active pharmaceutical ingredients and drug products, has launched an international sales office in Tokyo, Japan. The company is expanding its presence…

Almac Launches Pod Service
By

By
Almac Group, a Craigavon, Ireland-based contract development and manufacturing organization for active pharmaceutical ingredients and drug products, has launched its new Almac Pod shipping service in the US for clinical…